These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16519375)

  • 1. Concurrent cisplatin-based chemoradiation and adjuvant hysterectomy for bulky stage IB-IIA cervical cancer.
    Cheewakriangkrai C; Srisomboon J; Chitapanarux I; Suprasert P; Phongnarisorn C; Siriaree S; Charoenkwan K
    J Med Assoc Thai; 2005 Oct; 88(10):1331-7. PubMed ID: 16519375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative concurrent radiation therapy and chemotherapy for bulky stage IB2, IIA, and IIB carcinoma of the uterine cervix with proximal parametrial invasion.
    Huguet F; Cojocariu OM; Levy P; Lefranc JP; Darai E; Jannet D; Ansquer Y; Lhuillier PE; Benifla JL; Seince N; Touboul E
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1508-15. PubMed ID: 18676093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome for chemoradiotherapy in carcinoma of the cervix.
    Spensley S; Hunter RD; Livsey JE; Swindell R; Davidson SE
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):49-55. PubMed ID: 19081712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative concurrent daily low-dose cisplatin-based chemoradiation improves the prognosis of patients with pathologic T2b or N1 cervical cancer.
    Mitsuhashi A; Uno T; Usui H; Tate S; Hirashiki K; Kato K; Kiyohara H; Kato S; Ito H; Shozu M
    Anticancer Res; 2010 Jun; 30(6):2341-6. PubMed ID: 20651390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
    Elliott KS; Borowsky ME; Malka ES; Scudder SA; Leiserowitz GS; Russell AH
    J Reprod Med; 2006 May; 51(5):383-8. PubMed ID: 16779984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should simple hysterectomy be added after chemo-radiation for stage IB2 and bulky IIA cervical carcinoma?
    Eitan R; Levavi H; Peled Y; Brenner R; Sabah G; Ben-Arie A; Dgani R; Fishman A; Sulkes A; Fenig E; Koren C
    Aust N Z J Obstet Gynaecol; 2010 Jun; 50(3):289-93. PubMed ID: 20618249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.
    Keys HM; Bundy BN; Stehman FB; Muderspach LI; Chafe WE; Suggs CL; Walker JL; Gersell D
    N Engl J Med; 1999 Apr; 340(15):1154-61. PubMed ID: 10202166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of bulky stage IB and IA cervical cancer patients treated by radical hysterectomy with and without neoadjuvant chemotherapy: long-term follow-up.
    Manusirivithaya S; Chareoniam V; Pantusart A; Isariyodom P; Srisomboon J
    J Med Assoc Thai; 2001 Nov; 84(11):1550-7. PubMed ID: 11853297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer.
    Behtash N; Nazari Z; Ayatollahi H; Modarres M; Ghaemmaghami F; Mousavi A
    Eur J Surg Oncol; 2006 Dec; 32(10):1226-30. PubMed ID: 16952434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: surgical morbidity and oncological results.
    Colombo PE; Bertrand MM; Gutowski M; Mourregot A; Fabbro M; Saint-Aubert B; Quenet F; Gourgou S; Kerr C; Rouanet P
    Gynecol Oncol; 2009 Sep; 114(3):404-9. PubMed ID: 19555996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent cisplatin-based chemoradiation International Federation of Gynecology and Obstetrics stage IB2 cervical carcinoma.
    Goksedef BP; Kunos C; Belinson JL; Rose PG
    Am J Obstet Gynecol; 2009 Feb; 200(2):175.e1-5. PubMed ID: 19091305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of ("bulky") stage IB cervical cancer with or without neoadjuvant vincristine and cisplatin prior to radical hysterectomy and pelvic/para-aortic lymphadenectomy: a phase III trial of the gynecologic oncology group.
    Eddy GL; Bundy BN; Creasman WT; Spirtos NM; Mannel RS; Hannigan E; O'Connor D
    Gynecol Oncol; 2007 Aug; 106(2):362-9. PubMed ID: 17493669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
    Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF; Tseng CJ; Tseng CC; Yu CY; Wu CT; Chen WC
    Cancer J; 2008; 14(3):200-6. PubMed ID: 18536561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky".
    Sreenivasa G; Hildebrandt B; Kümmel S; Jungnickel K; Cho CH; Tilly W; Böhmer D; Budach V; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1159-67. PubMed ID: 16979843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of cervical cancer.
    Kesic V
    Eur J Surg Oncol; 2006 Oct; 32(8):832-7. PubMed ID: 16698223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma.
    Azria E; Morice P; Haie-Meder C; Thoury A; Pautier P; Lhomme C; Duvillard P; Castaigne D
    Ann Surg Oncol; 2005 Apr; 12(4):332-7. PubMed ID: 15827678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Completion hysterectomy after radiation therapy for bulky cervical cancer stages IB, IIA, and IIB: complications and survival rates.
    Decker MA; Burke JJ; Gallup DG; Silverio RW; Weems D; Duttenhaver J; Purcell D
    Am J Obstet Gynecol; 2004 Aug; 191(2):654-8; discussion 658-60. PubMed ID: 15343258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in uterine cervical cancer patients with high-risk factors.
    Kim YB; Cho JH; Keum KC; Lee CG; Seong J; Suh CO; Kim GE
    Gynecol Oncol; 2007 Jan; 104(1):58-63. PubMed ID: 16919718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.